Canadian Sec - Delayed Quote CAD
Braxia Scientific Corp. (BRAX.CN)
0.0050
0.0000
(0.00%)
At close: August 2 at 2:14:34 PM EDT
Key Executives
Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Peter Rizakos | CFO & Director | 134.04k | -- | -- |
Braxia Scientific Corp.
- Sector:
- Healthcare
- Industry: Biotechnology
Description
Braxia Scientific Corp. operates as a medical research company with clinics that provide ketamine treatments for persons with depression and related disorders. The company also owns and operates multidisciplinary clinics that offers treatment of mental health disorders. In addition, it is involved in the research activities related to discovering and commercializing novel drugs and delivery methods; and development and acquisition of derivatives of ketamine and psilocybin, as well as other psychedelic products from its IP development platform. The company is headquartered in Toronto, Ontario.
Corporate Governance
Braxia Scientific Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
March 17, 2025 at 10:59 AM UTC - March 18, 2025 at 12:00 PM UTC
Braxia Scientific Corp. Earnings Date
Recent Events
Recent Events Information Not Available
Related Tickers
COOL.CN Core One Labs Inc.
0.1450
0.00%
PHRM.CN PharmaTher Holdings Ltd.
0.1850
0.00%
BOLT Bolt Biotherapeutics, Inc.
0.3890
+4.57%
PHRRF PharmaTher Holdings Ltd.
0.1390
0.00%
MDMA.CN Pharmala Biotech Holdings Inc.
0.1400
0.00%
CYBN.NE Cybin Inc.
9.73
+1.88%
CTMX CytomX Therapeutics, Inc.
0.7658
+4.88%
ATAI Atai Life Sciences N.V.
1.5300
+0.66%
MNMD Mind Medicine (MindMed) Inc.
6.43
+5.24%